Bartoletti, Michele
 Distribuzione geografica
Continente #
NA - Nord America 533
AS - Asia 307
EU - Europa 262
SA - Sud America 9
AF - Africa 7
OC - Oceania 4
Totale 1.122
Nazione #
US - Stati Uniti d'America 527
SG - Singapore 146
CN - Cina 144
IE - Irlanda 96
FI - Finlandia 85
IT - Italia 21
DE - Germania 20
RU - Federazione Russa 20
MY - Malesia 8
EC - Ecuador 7
GB - Regno Unito 7
CA - Canada 6
EG - Egitto 5
KR - Corea 5
AU - Australia 4
FR - Francia 4
JP - Giappone 4
NL - Olanda 3
BR - Brasile 2
ES - Italia 2
SK - Slovacchia (Repubblica Slovacca) 2
CZ - Repubblica Ceca 1
ER - Eritrea 1
ET - Etiopia 1
SE - Svezia 1
Totale 1.122
Città #
Ashburn 165
Shanghai 132
Boardman 130
Singapore 111
Dublin 96
Helsinki 85
New York 70
Los Angeles 29
Moscow 20
Santa Clara 13
Seattle 11
Chandler 8
Cuenca 7
Kuala Lumpur 7
Phoenix 6
Wilmington 6
Cairo 5
Milan 5
Genoa 4
Queens 4
Belfast 3
Brisbane 3
Chapel Hill 3
Aix-en-Provence 2
Amsterdam 2
Ann Arbor 2
Banská Štiavnica 2
Barcelona 2
Bologna 2
Bristol 2
Brugherio 2
Buk-gu 2
Dongdaemun-gu 2
Glasgow 2
Guiyang 2
Lawrence 2
London 2
Nagareyama 2
Paris 2
Princeton 2
Rome 2
San Mateo 2
Sendai 2
Surrey 2
São Carlos 2
Addis Ababa 1
Asmara 1
Borås 1
Brno 1
Cinisello Balsamo 1
Clifton 1
Fairfield 1
Falkenstein 1
Hangzhou 1
Jiaxing 1
Leawood 1
Miami 1
Nantong 1
North York 1
Perth 1
Petaling Jaya 1
Rozzano 1
The Hague 1
Toronto 1
Totale 986
Nome #
Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study 64
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 32
Use of critical care resources during the first 2 weeks (February 24–March 8, 2020) of the Covid-19 outbreak in Italy 23
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 20
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure 17
A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol 17
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future 16
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 16
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 16
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis 15
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-alpha in HIV-infected patients treated with ritonavir-boosted protease inhibitors 14
Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae 14
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study 14
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 14
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis 13
Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018 13
The Gut Microbiota of Critically Ill Patients With COVID-19 13
A retrospective multicentre study on dalbavancin effectiveness and cost-evaluation in sternotomic wound infection treatment: DALBA SWIT Study 13
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 13
Klebsiella pneumoniae bloodstream infection epidemiology and impact of inappropriate empirical therapy 13
Carbapenemase-producing Enterobacteriaceae in transplant patients 13
Meningitis caused by toscana virus is associated with strong antiviral response in the CNS and altered frequency of blood antigen-presenting cells 13
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 12
Bloodstream infections in patients with liver cirrhosis 12
Opportunistic infections in end stage liver disease 12
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 12
Prevention of infections in nursing homes: Antibiotic prophylaxis versus infection control and antimicrobial stewardship measures 12
Characterization of antibody response in neuroinvasive infection caused by Toscana virus 12
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 12
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 12
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 12
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 11
Toscana virus infections in northern Italy: laboratory and clinical evaluation 11
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients 11
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 11
Quality of care indicators in the MAnageMent of BlOOdstream infections caused by Enterobacteriaceae (MAMBOO-E study): state of the art and research agenda 11
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections 11
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 11
Advances in the therapy of bacterial bloodstream infections 11
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 11
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 11
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis 11
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 11
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 10
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 10
Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy 10
Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation 10
Reply: Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 10
The role of procalcitonin in reducing antibiotics across the surgical pathway 10
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 10
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 10
Use of meropenem in treating carbapenem-resistant Enterobacteriaceae infections 10
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 10
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 10
The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosis 10
ESCMID COVID-19 living guidelines: drug treatment and clinical management 10
Infectious diseases team for the early management of severe sepsis and septic shock in the emergency department 10
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 10
Blood Hemoglobin Substantially Modulates the Impact of Gender, Morbid Obesity, and Hyperglycemia on COVID-19 Death Risk: A Multicenter Study in Italy and Spain 10
Risk Factors for Infection With Carbapenem-Resistant Klebsiella pneumoniae After Liver Transplantation: The Importance of Pre- and Posttransplant Colonization 10
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 10
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 10
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 10
Incidence and outcome of early Candida peritonitis after liver and pancreas transplantation 10
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection 9
Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study 9
COVID-19-associated pulmonary aspergillosis, March-August 2020 9
Clinical impact of reninangiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for coronavirus disease 2019 9
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients 9
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience 9
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 9
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in Candida spp colonized patients 9
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility 9
Genetic and Functional Characterization of Toll-Like Receptor Responses in Immunocompetent Patients With CMV Mononucleosis 9
Ursodeoxycholic Acid Does Not Improve COVID-19 Outcome in Hospitalized Patients 9
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study 8
Multidrug-Resistant Bacterial Infections in Solid Organ Transplant Candidates and Recipients 8
Classification performance for covid patient prognosis from automatic ai segmentation—a single-center study 8
Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections 8
Management of bacterial and fungal infections in cirrhosis: The MDRO challenge 8
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort 8
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 8
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 8
Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort study 8
Superficial swab versus deep-tissue biopsy for the microbiological diagnosis of local infection in advanced-stage pressure ulcers of spinal-cord-injured patients: a prospective study 8
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 8
Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions 8
The lower respiratory tract microbiome of critically ill patients with COVID-19 8
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 8
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 7
Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study 7
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 7
Treatment duration for Escherichia coli bloodstream infection and outcomes: Retrospective single-centre study 7
Prospective study on incidence, risk factors and outcome of recurrent clostridioides difficile infections 7
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study 7
Risk factors for candidemia after open heart surgery: Results from a multicenter case-control study 7
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 7
Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections 7
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 7
Procalcitonin-guided antibiotic therapy: An expert consensus 7
Totale 1.134
Categoria #
all - tutte 13.394
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.394


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 3 2 1 2 2 0 1
2021/20224 0 0 0 1 0 0 0 1 0 0 2 0
2022/2023134 4 0 2 3 0 3 0 2 4 2 111 3
2023/20241.043 62 70 203 37 62 171 89 52 17 50 118 112
2024/202558 30 8 17 3 0 0 0 0 0 0 0 0
Totale 1.250